Okay.
In your comments, you talked about making decisions within the context of limited supply. Do you think that the lack of vaccine supply in Canada to date, coupled with the threat of variants, played into the government's decision to approve the AstraZeneca vaccine for those aged 65 and older in spite of your recommendation?